Drug copayment coupons to reduce patient cost-sharing have become nearly ubiquitous for high-priced brand-name prescription drugs. Medicare bans such coupons on the grounds that they are kickbacks that induce utilization, but they are commonly used by commercially-insured enrollees. We estimate...

Settlements of drug patent disputes that involve a potential payment from the brand to the generic signal a possible collusive profit split with a threat to competition, and have undergone intensive scrutiny in the literature on law and economics. A common feature of these brand-generic...

Identifying sources of vaccine hesitancy is one of the central challenges in fighting the Covid- 19 pandemic. In this study, we focus on the role of public misperceptions of doctors' views. Motivated by widespread concern that media reports create uncertainty in how people perceive expert...

Crestor, an important but controversial cholesterol-lowering drug, is contraindicated for use by senior and Asian patients. In this paper, we exploit this fact and a unique doctor-level prescription and advertising (detailing, to be exact) exposure data for statin drugs to examine the hypothesis...

India has now seen pharma players taking the e-commerce route, with an intention to offer a solution to a number of problems, plaguing the retail pharmacy industry. The development of internet has transformed the process of consumer choice, in every spectrum of market. In health care system, it...

Pharmacogenomics, or the application of genetic testing to guide drug selection and/or dosing, is often cited as integral to the vision of how precision medicine can be integrated into routine clinical practice. Yet despite a growing base of scientific discovery on genetic variation that...

Problem de finition: The inventory control problem associated with the distribution of essential medicines in Zambia involves seasonality and uncertainty in both demand and lead-times, heterogeneous delivery locations, and lost sales. Beyond the traditional performance metrics of system service...

We conducted a survey by mail in 2013 of randomly selected economics professors in the United States about the welfare effects of three proposed policy reforms. We received back 574 completed surveys (a 19 percent response rate). A large majority supported a reform to increase immigration into...

Effectively designed market mechanisms may reduce growth in health care spending. In this paper, we study the impact of privatizing the delivery of Medicaid drug benefits on drug spending. Exploiting granular data that allow us to examine drug utilization, we find that drug spending would fall...

We use sharp, massive and unexpected price increases of oral contraceptives—product of a documented case of collusion among pharmaceutical retailers in Chile—as a natural experiment to estimate the impact of access to the Pill on fertility and newborn health. Our empirical strategy combines...